A placebo-controlled randomized cross-over lovastatin trial in neurofibromatosis type 1 reveals Ras/MAPK modulation of dynamic emotional face processing
Scientific Reports, Published online: 06 October 2026; doi:10.1038/s41598-026-72672-y A placebo-controlled randomized cross-over lovastatin trial in neurofibromatosis type 1 reveals Ras/MAPK modulation of dynamic emotional face processing
We haven't written up this one. Scientific Reports has the full story — the link below goes straight to it.